ArticleAmerican journal of cancer research2019

Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells.

Ye Han et al.PubMed ↗Full text ↗

No numbers read from the abstract.